Lower Urinary Tract Symptoms are Associated with Erectile Function and Psychological Symptoms in Men with Late‐Onset Hypogonadism Syndrome

We assessed the factors significantly associated with lower urinary tract symptoms (LUTS) in men with late‐onset hypogonadism (LOH) syndrome.

[1]  G. Schatzl,et al.  Lower urinary tract symptoms and depression , 2012, BJU international.

[2]  T. Hour,et al.  Associations of the lower urinary tract symptoms with the lifestyle, prostate volume, and metabolic syndrome in the elderly males , 2012, The aging male : the official journal of the International Society for the Study of the Aging Male.

[3]  M. Namiki,et al.  Late-Onset Hypogonadism Syndrome and Lower Urinary Tract Symptoms , 2011, Korean journal of urology.

[4]  N. Masumori,et al.  Animal model for the study of the relationship between lower urinary tract symptoms/bladder outlet obstruction and erectile dysfunction , 2011, International journal of urology : official journal of the Japanese Urological Association.

[5]  Toshiaki Tanaka,et al.  The Effect of Tamsulosin Treatment on Erectile Functions in Patients with Lower Urinary Tract Symptoms (LUTS) due to Benign Prostate Hyperplasia: Correlation between Improvement of LUTS and Erectile Function , 2011, Lower urinary tract symptoms.

[6]  T. Iwamoto,et al.  Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study , 2011, The aging male : the official journal of the International Society for the Study of the Aging Male.

[7]  T. Iwamoto,et al.  Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients , 2010, The aging male : the official journal of the International Society for the Study of the Aging Male.

[8]  H. Yoon,et al.  Correlation between Metabolic Syndrome and Lower Urinary Tract Symptoms of Males and Females in the Aspect of Gender-Specific Medicine: A Single Institutional Study , 2010 .

[9]  R. Dmochowski,et al.  Urodynamic Effects of Once-Daily Tadalafil in Men with LUTS Secondary to Clinical BPH , 2010, Current urology reports.

[10]  M. Zitzmann.  Testosterone deficiency, insulin resistance and the metabolic syndrome , 2009, Nature Reviews Endocrinology.

[11]  S. Jang,et al.  UP-3.072: Association Between Lower Urinary Tract Symptoms and Erectile Dysfunction in Aging Men: Hallym Aging Study , 2009 .

[12]  J. Mckinlay,et al.  Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. , 2009, The Journal of urology.

[13]  J. Morley,et al.  The benefits and risks of testosterone replacement therapy: a review , 2009, Therapeutics and clinical risk management.

[14]  R. Levin,et al.  Effects of chronic treatment with vardenafil, a phosphodiesterase 5 inhibitor, on female rat bladder in a partial bladder outlet obstruction model , 2009, BJU international.

[15]  T. Yanase,et al.  Late‐onset hypogonadism (LOH) and androgens: Validity of the measurement of free testosterone levels in the diagnostic criteria in Japan , 2009, International journal of urology : official journal of the Japanese Urological Association.

[16]  F. Saad,et al.  Lower urinary-tract symptoms and testosterone in elderly men , 2008, World Journal of Urology.

[17]  A. Seftel,et al.  Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction , 2008, International Journal of Impotence Research.

[18]  M. Yoo,et al.  Effects of phosphodiesterase type 5 inhibitor on the contractility of prostate tissues and urethral pressure responses in a rat model of benign prostate hyperplasia , 2007, International journal of urology : official journal of the Japanese Urological Association.

[19]  P. Sandner,et al.  Pre‐clinical evidence for the use of phosphodiesterase‐5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms , 2006, BJU international.

[20]  J. Woo,et al.  Lower urinary tract symptoms and depressive symptoms in elderly men. , 2006, Journal of affective disorders.

[21]  G. Bartsch,et al.  Persistent detrusor overactivity after transurethral resection of the prostate is associated with reduced perfusion of the urinary bladder. , 2006, BJU international.

[22]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[23]  K. McVary.  Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology , 2006, BJU international.

[24]  A. Esen,et al.  ASSOCIATION BETWEEN LOWER URINARY TRACT SYMPTOMS AND ERECTILE DYSFUNCTION , 2006, Archives of andrology.

[25]  B. Lunenfeld,et al.  ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: Scientific background and rationale , 2005, The aging male : the official journal of the International Society for the Study of the Aging Male.

[26]  K. McVary.  Erectile dysfunction and lower urinary tract symptoms secondary to BPH. , 2005, European urology.

[27]  A. Araujo,et al.  Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. , 2004, The Journal of clinical endocrinology and metabolism.

[28]  P. Boyle,et al.  [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)]. , 2003, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[29]  M. Barry,et al.  Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. , 2002, Urology.

[30]  Xiulin Liu,et al.  Identification and functional study of phosphodiesterases in rat urinary bladder , 2001, Urological Research.

[31]  M. Barry,et al.  Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. , 2001, Journal of clinical epidemiology.

[32]  E. Metter,et al.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. , 2001, The Journal of clinical endocrinology and metabolism.

[33]  F. Comhaire,et al.  Andropause: Hormone Replacement Therapy in the Ageing Male , 2000, European Urology.

[34]  R. Krane,et al.  Overactivity and structural changes in the chronically ischemic bladder. , 1999, The Journal of urology.

[35]  A. Burnett,et al.  The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. , 1995, Fertility and sterility.